本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cogent Biosciences, Inc.

33.41
-0.6700-1.97%
盘后33.410.00000.00%19:57 EDT
成交量:171.58万
成交额:5,763.47万
市值:57.97亿
市盈率:-15.47
高:35.00
开:34.51
低:33.21
收:34.08
52周最高:43.73
52周最低:11.60
股本:1.74亿
流通股本:1.67亿
量比:1.05
换手率:1.03%
股息:- -
股息率:- -
每股收益(TTM):-2.1600
每股收益(LYR):-2.5504
净资产收益率:-109.74%
总资产收益率:-43.84%
市净率:12.40
市盈率(LYR):-13.10

数据加载中...

2024/12/09

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/27

重要事件披露

Form 8-K - Current report
2024/06/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/05

重要事件披露

Form 8-K - Current report
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/09

SEC问询函

Form CORRESP - Correspondence
2024/04/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/27

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]